On September 12, 2017, the U.S. Food and Drug Administration (FDA) released the final guidance that outlines the agency’s expectations and recommendations for the evaluation and reporting of age-, race-, and ethnicity-specific data in medical device clinical studies.
Please see full publication below for more information.